Alejandra González‐Duarte

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Scott D. Solomon, David Adams, Arnt V. Kristen et al. · Circulation · 2019 · 461 citations

Medicine, Cardiology, Pharmacotherapy +9

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

David Adams, Ivailo Tournev, Mark Taylor et al. · Amyloid · 2022 · 379 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Mathew S. Maurer, Parag Kale, Marianna Fontana et al. · New England Journal of Medicine · 2023 · 307 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke

George Ntaios, Patrik Michel, Georgios Georgiopoulos et al. · Stroke · 2020 · 284 citations · Full text

Medicine, Infectious Diseases, Cerebrovascular Neurosurgery +15